Right Targets. Right Cells. Right Place.

Right Targets
Right Cells
Right Place

Unlocking the power of T cells against oncogenic driver mutations

Latest News

Affini-T Therapeutics to Present AFNT-211 T Cell Product Attributes Targeting KRAS G12V at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

Affini-T Therapeutics to Present Novel CRISPR Gene Editing Data from its Oncogenic Driver Program Targeting KRAS at the American Society of Gene and Cell Therapy 26th Annual Meeting

TEAM

TECHNOLOGY

PIPELINE